ABSTRACT
Genes carried on the type 3 secretion system (T3SS) pathogenicity island of Vibrio cholerae non-O1/non-O139 serogroup strain AM-19226 must be precisely regulated in order for bacteria to cause disease. Previously reported results showed that both T3SS function and the presence of bile are required to cause Caco2-BBE cell cytotoxicity during coculture with strain AM-19226. We therefore investigated additional parameters affecting in vitro cell death, including bacterial load and the role of three transmembrane transcriptional regulatory proteins, VttRA, VttRB, and ToxR. VttRA and VttRB are encoded on the horizontally acquired T3SS genomic island, whereas ToxR is encoded on the ancestral chromosome. While strains carrying deletions in any one of the three transcriptional regulatory genes are unable to cause eukaryotic cell death, the results of complementation studies point to a hierarchy of regulatory control that converges on vttRB expression. The data suggest both that ToxR and VttRA act upstream of VttRB and that modifying the level of either vttRA or vttRB expression can strongly influence T3SS gene expression. We therefore propose a model whereby T3SS activity and, hence, in vitro cytotoxicity are ultimately regulated by vttRB expression.
IMPORTANCE In contrast to O1 and O139 serogroup V. cholerae strains that cause cholera using two main virulence factors (toxin-coregulated pilus [TCP] and cholera toxin [CT]), O39 serogroup strain AM-19226 uses a type 3 secretion system as its principal virulence mechanism. Although the regulatory network governing TCP and CT expression is well understood, the factors influencing T3SS-associated virulence are not. Using an in vitro mammalian cell model to investigate the role of three ToxR-like transmembrane transcriptional activators in causing T3SS-dependent cytotoxicity, we found that expression levels and a hierarchical organization were important for promoting T3SS gene expression. Furthermore, our results suggest that horizontally acquired, ToxR-like proteins act in concert with the ancestral ToxR protein to orchestrate T3SS-mediated pathogenicity.
INTRODUCTION
Pathogenic bacteria must effectively control the expression of virulence factors in order to achieve productive infection. As a waterborne pathogen, Vibrio cholerae senses and responds to signals from two distinct environments, the aquatic reservoir and the human host, requiring appropriate temporospatial changes in gene expression. Epidemic-causing O1 and O139 serogroup strains use the ToxR-ToxT regulatory hierarchy to modulate the expression of genes encoding factors responsible for colonization (toxin-coregulated pilus [TCP]) and diarrhea (cholera toxin [CT]) (1, 2). Whereas toxR is an ancestral gene found in all V. cholerae strains, toxT is carried on horizontally acquired Vibrio pathogenicity island 1 (VPI-1), which encodes the TCP. ToxR can directly activate transcription from the toxT promoter (3, 4). VPI-1 also encodes the TcpPH proteins, which can increase toxT transcription and are required for optimal virulence gene expression (5). In addition, the AphAB proteins positively regulate tcpPH expression and, like toxR, are encoded in ancestral genomic loci (6–8). Thus, a complex network of regulators is involved in modulating the expression of horizontally acquired virulence factors in TCP/CT-positive V. cholerae strains.
Pathogenic strains of other serogroups, collectively called non-O1/non-O139 serogroup strains, typically do not encode the TCP or CT and instead encode other virulence factors (9–19). Although the mechanisms resulting in non-O1/non-O139 serogroup-associated disease are less well understood, we now know that a subset of non-O1/non-O139 serogroup strains carries genes for a type 3 secretion system (T3SS) (20–23). Previous studies using O39 serogroup strain AM-19226, which lacks the TCP and CT, have shown that T3SS activity is required for colonization and disease in murine and rabbit animal models of infection (24, 25). T3SS genomic island-encoded, translocated proteins have been identified and named Vops, and several Vops have been assigned functions (25–30).
VttRA and VttRB are two transcriptional regulators encoded within the T3SS genomic island. Both proteins are integral membrane proteins with N-terminal, cytoplasmic DNA binding domains and overall sequence similarity to ToxR (31). ΔvttRA and ΔvttRB strains are severely attenuated for colonization in vivo and deficient in bile-mediated enhancement of T3SS gene expression in vitro (31, 32). Consistent with other V. cholerae strains, AM-19226 also encodes ToxR. We previously reported that the AM-19226 ToxR protein contributes to T3SS-related in vitro and in vivo phenotypes but has a less prominent role than VttRA and VttRB (31, 32). However, the different parameters that govern in vitro versus in vivo phenotypes and the molecular regulatory events that shape virulence remain poorly defined.
Coculture of strain AM-19226 with the Caco2-BBE intestinal epithelial cell line results in rapid eukaryotic cell death in the presence of bile (32). The phenotype does not require the HlyA hemolysin or the putative thermostable direct-related hemolysin (TRH) but requires a functional T3SS. We therefore sought to further examine the bacterial requirements during coculture and the roles of VttRA and VttRB in bile-mediated Caco2-BBE cell death. We included ToxR in our studies since its role in the coculture assay had not previously been examined; we were interested in further understanding how ToxR influences horizontally acquired virulence gene expression in TCP/CT-negative strains. We present genetic data supporting a model that correlates levels of vttRA and vttRB gene expression with T3SS gene expression and mammalian cell cytotoxicity in vitro. Furthermore, our results suggest an important role for ToxR in modulating T3SS virulence phenotypes by modifying vttRB expression levels.
MATERIALS AND METHODS
Bacterial strains, growth conditions, and in silico analysis.
Strains (Table 1) were maintained and grown under standard conditions and as described below. Ampicillin (Amp) and streptomycin (Str) were used at 100 μg/ml for Escherichia coli and V. cholerae. Bile (bovine bile, catalog number B3883; Sigma) was prepared as previously described (31). Clone Manager Professional Suite, version 9 (Sci-Ed Software), was used for sequence analysis.
TABLE 1.
Strains used in this study
| Strain | Genotype or descriptiona | Source or reference |
|---|---|---|
| V. cholerae | ||
| MD992 | AM-19226 R− M+ Strr | Laboratory stock |
| AAC228 | MD992 ΔvttRA | 31 |
| AAC477 | MD992 ΔvopX | 26 |
| AAC155 | MD992 Δhap ΔhlyA ΔrtxA | 26 |
| AAC295 | AAC155 ΔvttRA | This study |
| AAC291 | AAC155 ΔvttRB | This study |
| AAC287 | AAC155 ΔtoxR | This study |
| MS156 | AAC155 ΔvttRA ΔvttRB | This study |
| AAC473 | AAC155 ΔvopX | This study |
| CHS2-13 | AAC473 with vopX | This study |
| JC9 | AAC155 vopX′ | This study |
| E. coli | ||
| DH5αλpir | F− ϕ80dlacΔM15 Δ(lacZYA-argF)U169 endA1 recA1 hsdR17 deoR thi-1 supE44 gyrA96 (Nalr) relA1 λpir | Laboratory stock |
| SM10λpir | thi thr leu tonA lacY supE recA RP4-2-Tc::(λpir) Kanr | Laboratory stock |
Strr, streptomycin resistant; Nalr, nalidixic acid resistant; Kanr, kanamycin resistant; R−, type II restriction endonuclease deletion; M+, methyltransferase positive.
Strain and plasmid construction.
Nucleic acid manipulations were performed by using standard molecular biology techniques (33). Strain MD992 was used as the wild-type (WT) parental strain for β-galactosidase assays and strain derivatives. For coculture assays, MD992 lacking hap, hlyA, and rtxA (AAC155) was used as the parental strain (26). toxR, vttRA, vttRB, or vopX deletions were constructed in AAC155 as previously described (26, 31). pBAD18-toxR was constructed by using restriction enzyme-based methods to insert the open reading frame downstream of the arabinose-inducible promoter (Table 2).
TABLE 2.
Plasmids used in this study
| Plasmid | Descriptiona | Reference |
|---|---|---|
| pCVD442 | Suicide vector; Ampr | 40 |
| pMD86 | pCVD442-based vector carrying 5′ and 3′ V. cholerae lacZ sequences for allelic exchange; Ampr | This study |
| pAAC3 | Vector containing E. coli lacZY for construction of transcriptional fusions; Ampr | 31 |
| pAAC3-vcsRTCNS2 | Vector containing vcsRTCNS2-lacZY; Ampr | 31 |
| pAAC3-vcsJ2 | Vector containing vcsJ2-lacZY; Ampr | 31 |
| pAAC3-vttRB | Vector containing vttRB-lacZY; Ampr | 31 |
| pBAD18 | Expression vector, arabinose inducible; Ampr | 35 |
| pBAD18-vttRA | VttRA expression vector; Ampr | 32 |
| pBAD18-vttRB | VttRB expression vector; Ampr | 32 |
| pBAD18-toxR | ToxR expression vector; Ampr | This study |
Ampr, ampicillin resistant.
For VopX complementation studies, a wild-type copy of vopX, including ∼500 bp of native sequences upstream of the translational start site, was integrated into the AM-19226 lacZ locus by using plasmid pMD86. The vopX′ truncation was constructed by using pCVD442-ΔvttRA, which contains the vopX coding sequence and sequences homologous to the AM-19226 genome, allowing for allelic exchange of an engineered nucleotide point mutation that introduced a stop codon (A157T, resulting in amino acid change K54X). DNA sequencing analyses confirmed genomic integration of the point mutation. Primer sequences are available upon request.
β-Galactosidase assay.
Multicopy pAAC3 plasmids carrying transcriptional lacZ reporter fusions to vcsRTCNS2, vcsJ2, and vttRB were previously described (31). Kinetic β-galactosidase assays were performed as previously described, where units equal micromoles o-nitrophenyl-β-d-galactopyranoside (ONPG) hydrolyzed per minute per optical density at 600 nm (OD600) (31).
Mammalian cell lines and culture conditions.
Caco2-BBE cells were routinely maintained in Dulbecco's modified Eagle medium (DMEM) (4.5 mg/ml glucose, sodium pyruvate, and l-glutamine; Invitrogen) supplemented with 10% fetal bovine serum (FBS) (Gemini Bio-Products) at 37°C with 5% CO2. Coculture of Caco2-BBE cells and V. cholerae strain AM-19226 was performed in the presence of DMEM supplemented with 5% FBS as previously described, using DMEM containing 1 mg/ml glucose (low-glucose medium; Invitrogen) for arabinose induction experiments (32).
Lactate dehydrogenase release assay.
Percent cytotoxicity was determined as previously described, using the CytoTox 96 nonradioactive cytotoxicity assay (Promega) according to the manufacturer's instructions (32). Briefly, Caco2-BBE cells were seeded into 96-well plates, grown for ∼24 h (80% confluence), and infected at a multiplicity of infection (MOI) of ∼10 (unless otherwise noted) using strains grown overnight at 37°C in LB medium. Bile and/or arabinose was added to the coculture medium as indicated. A total of 0.5 mg/ml gentamicin was added during coculture where indicated, which is a concentration previously confirmed to result in 100% bacterial killing.
Statistical analyses.
Statistical analyses were conducted by using GraphPad Prism with 2-way analysis of variance (ANOVA) followed by Dunnett or Tukey post hoc tests as appropriate.
RESULTS
Bacterial MOI modulates cytotoxicity.
To investigate how the bacterial MOI modulates the kinetics of cell death, we infected Caco2-BBE cells with AM-19226 at MOIs ranging from ∼1 to 300. For reference, under our standard conditions of an MOI of ∼10 in the presence of 0.2% bile, we observed ∼30% cytotoxicity at 2 h postinfection (hpi) and ∼80% cytotoxicity at 3 hpi, as measured by lactase dehydrogenase (LDH) release and consistent with previous results (Fig. 1) (32). Infection at an MOI of ∼1 decreases cytotoxicity to <10% at 2 hpi and to ∼45% at 3 hpi, while an increase of the MOI to 39 results in increased cytotoxicity at 2 hpi (∼65%) but does not increase cell death above ∼80% at 3 hpi. Infection at an MOI of ≥75 results in ∼80% cytotoxicity after 2 hpi, which was not increased at 3 hpi (Fig. 1 and data not shown). Therefore, increasing the MOI above 10 shortened the time to maximal LDH release and thus cytotoxicity but did not increase the percentage of cytotoxic cells after 3 h of coculture.
FIG 1.

Multiplicity of infection influences kinetics of Caco2-BBE cell cytotoxicity. The AM-19226 T3SS WT strain was grown overnight in LB medium and used to infect Caco2-BBE cells at various MOIs in the presence of 0.2% bile. Percent cytotoxicity was determined by measuring LDH levels in the coculture supernatant 2 h (gray bars) or 3 h (black bars) after infection. The experiment was performed by using three AM-19226 colonies and was repeated, with similar results.
Cytotoxicity requires viable bacteria.
Given that the bacterial burden can modulate the kinetics of cytotoxicity, we asked whether live bacteria are required throughout the 3 h of infection or whether a short incubation with bacteria was sufficient to initiate the process. Following the addition of bacteria in the presence of bile, we added gentamicin at 0.5-h intervals from 0 to 2.5 hpi and measured LDH release at 3 hpi. We did not observe cytotoxicity when gentamicin was added at the time of infection (0 h) or at 0.5, 1, or 1.5 hpi (Fig. 2). However, we measured ∼40% cytotoxicity when gentamicin was added to the coculture medium at 2 hpi, a time point at which the bacterial count increased 2- to 4-fold (Fig. 2 and data not shown). Levels of replication were similar for T3SS-positive and T3SS-negative strains and increased 15- to 20-fold over that of the initial inoculum (MOI = 10) at 3 hpi (data not shown). Interestingly, the addition of gentamicin at 2.5 hpi did not alter the cytotoxicity levels compared to levels achieved in the absence of gentamicin (our standard infection conditions) (Fig. 2). The collective data therefore suggest that cytotoxicity requires viable bacteria for a period of at least 2 h postinfection.
FIG 2.

Addition of gentamicin halts progression of mammalian cell cytotoxicity. Three colonies of the AM-19226 T3SS WT strain were grown overnight in LB medium and used to infect Caco2-BBE cells at an MOI of ∼10 in the presence of 0.2% bile. Gentamicin was added to individual coculture wells at 0.5-h intervals between 0 h and 2.5 h following infection to kill bacterial cells. After the addition of gentamicin, the coculture was continued until 3 h from initial infection, and percent cytotoxicity was determined. Data are representative of results from two independent experiments.
VttRA and VttRB are required for AM-19226-mediated mammalian cell cytotoxicity.
Previous results from our laboratory showed that VttRA and VttRB modulate T3SS island gene expression in vitro in the presence of bile (31, 34). Data also support a model for hierarchical regulation whereby VttRA regulates the expression of vttRB, since both a ΔvttRA single-deletion strain and a ΔvttRA ΔvttRB double-deletion strain can be complemented for T3SS gene expression by providing vttRB in trans (32).
We therefore assessed the contribution of each regulator to AM-19226-induced Caco2-BBE cell cytotoxicity. We used single- and double-deletion strains that were complemented by using pBAD-based plasmids expressing either vttRA or vttRB, grown in the presence of two different arabinose (inducing) concentrations. Figure 3 shows ∼70 to 80% Caco2-BBE cell cytotoxicity resulting from infection with the AM-19226 T3SS WT strain carrying the pBAD18 vector alone when strains were grown under all conditions. Coculture with strains deleted for either vttRA or vttRB does not result in cytotoxicity in the absence of arabinose, similar to results obtained when a ΔvcsN2 (T3SS-deficient) strain was used for infection (Fig. 3, black bars) (32). For ΔvttRA(pBAD18-vttRA) complementation analyses, cytotoxicity was observed only when 0.5% arabinose was included during coculture (Fig. 3, gray bars). However, we observed increased cytotoxicity during infection with the AM-19226 ΔvttRB strain carrying pBAD18-vttRB when 0.05% or 0.5% arabinose was included during coculture (Fig. 3, checkered and gray bars). Expression of vttRB with 0.05% or 0.5% arabinose in AM-19226 ΔvttRA cells also restored cytotoxicity, whereas vttRA expression in the ΔvttRB background did not. Notably, restoration of cytotoxicity in a ΔvttRA ΔvttRB strain was achieved only by expression of vttRB (Fig. 3, checkered and gray bars). These results are consistent with data from studies measuring T3SS structural gene expression in deletion strains using lacZ transcriptional reporter fusions, in which expressing vttRB alone complemented a ΔvttRA ΔvttRB strain (31, 32). Together, our studies demonstrate that vttRA cannot replace vttRB and suggest that a hierarchy of T3SS gene expression exists where vttRA is epistatic to vttRB.
FIG 3.
vttRA functions upstream of vttRB to tightly regulate Caco2-BBE cell cytotoxicity. The AM-19226 T3SS WT, ΔvttRA, ΔvttRB, or ΔvttRA ΔvttRB strain carrying pBAD18, pBAD18-vttRA, or pBAD18-vttRB was grown overnight in LB medium and used to infect Caco2-BBE cells at an MOI of ∼10 in the presence of 0.2% bile. Arabinose at a concentration of 0%, 0.05%, or 0.5% was included in the coculture medium to induce vttRA or vttRB expression. Percent cytotoxicity was determined after 3 h of coculture. Data shown are from one experiment using three colonies of each AM-19226 strain. ** indicates a P value of <0.0001, and * indicates a P value of between 0.001 and 0.0001. The experiment was repeated, with similar results.
ToxR activity has critical functions in modulating gene expression and cytotoxicity.
T3SS structural gene-lacZ reporter fusion studies suggested that ToxR affects T3SS gene expression in vitro ∼2-fold, whereas more dramatic effects were observed for ΔvttRA andΔvttRB strains (31). Similar trends were observed by using the infant mouse model, where ΔvttRA and ΔvttRB strains were severely attenuated for colonization (100- to 1,000-fold) and a ΔtoxR strain had an ∼10-fold defect (31). We therefore determined whether ToxR has a role in effecting Caco2-BBE cell cytotoxicity. The results shown in Fig. 4, comparing cytotoxicity levels during coculture with a T3SS WT strain, a toxR deletion strain, and the ΔtoxR strain complemented with pBAD18-toxR, clearly indicate that ToxR is absolutely required for mammalian cell death under the conditions of our assay (Fig. 4A, black bars). The pBAD18-toxR construct restored cytotoxicity in the ΔtoxR strain when levels of arabinose of up to 0.2% were included in the growth medium and even when no arabinose was present. Coculture assays performed with medium that contained a higher concentration of glucose (4.5 mg/ml) did not result in complementation in the absence of arabinose, supporting our conclusion that leaky expression of toxR from the arabinose-inducible promoter occurs in low-glucose tissue culture medium and provides sufficient levels of toxR to restore cytotoxicity (data not shown) (35). Interestingly, cocultures including higher levels of arabinose in the medium (0.5%) did not result in cytotoxicity during infection with the ΔtoxR(pBAD18-toxR) strain (Fig. 4A, gray bars).
FIG 4.

ToxR activity is integrated into the regulatory network governing Caco2-BBE cell cytotoxicity. The AM-19226 T3SS WT or ΔtoxR strain carrying pBAD18 (A and B), pBAD18-toxR (A and B), pBAD18-vttRA (B), or pBAD18-vttRB (B) was grown overnight in LB medium and used to infect Caco2-BBE cells at an MOI of ∼10 in the presence of 0.2% bile. Arabinose was included in the coculture medium at the indicated concentrations to induce toxR, vttRA, or vttRB expression. Percent cytotoxicity was determined after 3 h of coculture. Data for each panel represent results from one experiment with three colonies of each AM-19226 strain. ** indicates a P value of <0.0001. Each experiment was repeated, with similar results.
To examine the possibility that ToxR modulates the cytotoxicity phenotype by interacting within the VttRA/VttRB hierarchy, we tested whether the expression of vttRA or vttRB from a pBAD-based arabinose-inducible promoter can complement a toxR deletion strain for the cytotoxicity phenotype. Based on the results shown in Fig. 3, we included 0%, 0.05%, or 0.5% arabinose in the coculture medium. As shown in Fig. 4B, induction of vttRA expression with 0.5% arabinose or of vttRB expression with 0.05% or 0.5% arabinose completely restored cytotoxicity in the ΔtoxR strain. Our data therefore suggest that ToxR acts upstream of VttRA/VttRB. This conclusion is supported by lacZ transcriptional fusion reporter data showing decreased vttRB expression in a ΔtoxR strain and is consistent with our interpretation that a transcriptional hierarchy results in vttRB expression and subsequent activity that is responsible for T3SS gene expression (31, 32).
vttRA regulatory regions overlap the vopX coding sequence.
During the course of parallel studies investigating the requirement for different T3SS-translocated proteins (Vops) for cytotoxicity, we found that a ΔvopX strain did not cause cytotoxicity (K. A. Miller, C. H. Seward, and M. Dziejman, unpublished results). Although we constructed the strain as an unmarked, in-frame deletion, we were unable to complement the vopX defect by providing a chromosomally encoded wild-type copy of vopX that included its endogenous promoter (Fig. 5A). The vopX and vttRA genes are adjacent and divergently transcribed, with 238 bp between the translational start sites of the two coding sequences (Fig. 6A). We recognized that the ΔvopX deletion, which was constructed to remove almost the entire open reading frame, could impact sequences required for vttRA expression and thus influence T3SS gene expression. To test our hypothesis, we conducted β-galactosidase assays using isogenic wild-type, ΔvttRA, and ΔvopX strains carrying plasmid-based lacZ transcriptional reporter fusions to promoters previously shown to be VttRA regulated: vcsRTCNS2, vcsJ2 (T3SS structural gene operons), and vttRB (31). Consistent with previously reported results, the vttRA deletion strain exhibited an ∼5- to 15-fold decrease in structural gene expression compared to that of the wild-type strain (Fig. 5B, compare black and gray bars) (31). Interestingly, similar trends were found for the ΔvopX strain (Fig. 5B, compare black and light gray bars). vttRB expression levels were also decreased, further suggesting that the T3SS regulatory network and, consequently, T3SS gene expression are altered in the vopX deletion strain.
FIG 5.

vttRA expression levels influence cytotoxicity, via vttRB expression. Percent cytotoxicity was measured after 3 h of Caco2-BBE/AM-19226 cell coculture in the presence of 0.2% bile (A, C, and D). (A) Coculture was performed with the parental T3SS WT strain or the ΔvopX strain carrying a wild-type copy of vopX and its native promoter in the AM-19226 lacZ locus (ΔvopX + vopX). (B) β-Galactosidase activity was measured in the AM-19226 WT, ΔvttRA, or ΔvopX strain grown for 16 h at 37°C in LB medium supplemented with 0.4% bile. Each strain carried a pAAC3 plasmid with vcsRTCNS2, vcsJ2, vttRB, or promoterless (pr-less) transcriptional lacZ fusions. Statistical analysis comparing the mean for the WT strain to those for the ΔvttRA and ΔvopX strains resulted in P values of <0.0001 for all reporter fusions. (C) Coculture was performed in the presence of 0%, 0.05%, or 0.5% arabinose. The following strain backgrounds were used: T3SS WT, ΔvopX, ΔvttRA, and ΔvttRB. All strains carry pBAD18, pBAD18-vttRA, or pBAD18-vttRB. Statistical analysis comparing each mean at different arabinose concentrations to the mean at 0% arabinose for the strains expressing vttRA or vttRB identified P values of <0.0001 in all cases except where indicated (ns, not significant). (D) Coculture was performed by using the T3SS WT strain and the strain expressing the VopX′ truncation mutant (vopX null). For each panel, data shown are from one experiment using three colonies per strain. Each assay was performed at least twice.
FIG 6.

Schematic of the vopX-vttRA locus and model for T3SS gene regulation. (A) vttRA and vopX gene positions are indicated relative to the 238-bp intergenic region. Arrows indicate predicted transcriptional start sites (+1) based on transcriptome analyses, with 26 bp between the vopX +1 site and the VopX coding sequence and 60 bp between the +1 site and the coding sequence for VttRA (34). Sequences absent in the vopX deletion strain are indicated by the triangle above the gene. (B) Model based on data presented here and by Alam et al. (31), whereby both positive regulation and negative regulation affect the expression of VttRB. A positive regulator of vttRA expression has not yet been identified, although transcriptional reporter data indicate that expression may be negatively regulated by VttRA itself and ToxR. In this model, each regulatory protein has the ability to act both positively and negatively to modulate transcription.
We reasoned that the vopX deletion strain could not cause cytotoxicity due to decreased vttRA expression rather than the lack of VopX. We thus predicted that expression of vttRA or vttRB would complement the cytotoxicity defect. Figure 5C shows the results of such complementation experiments. Coculture of Caco2-BBE cells with the AM-19226 ΔvopX strain expressing either vttRA or vttRB resulted in cytotoxicity levels similar those achieved by using the isogenic parental strain (Fig. 5C, compare black and gray bars). We therefore conclude that the ΔvopX phenotype can be complemented by the expression of vttRA or vttRB.
To provide additional evidence that cytotoxicity required wild-type levels of vttRA expression, we constructed a point mutation in vopX that introduced a premature stop codon at amino acid 54 (vopX′). The strain was therefore VopX null but VttRA WT. Coculture of Caco2-BBE cells with the AM-19226 vopX′ strain caused cytotoxicity levels similar to those of the parental strain (Fig. 5D). Taken together, these data suggest that the VopX-coding region overlaps vttRA regulatory sequences that are critical for producing levels of vttRA expression that in turn result in wild-type T3SS gene expression levels, presumably through precise levels of vttRB expression.
DISCUSSION
Transmembrane transcriptional regulatory proteins are a hallmark of gene regulation in V. cholerae, and T3SS-positive strains encode three such regulators: VttRA, VttRB, and ToxR. We previously demonstrated that each protein influences T3SS gene expression to different extents, but in the experiments reported here, we found that each protein is essential for bacteria to cause mammalian cell cytotoxicity during in vitro coculture. We therefore sought to better understand the bacterial parameters and regulatory network influencing cytotoxicity.
When complementing the vttRA and vttRB deletions, the results of inducible expression studies suggest that different minimum levels of gene expression are required to achieve wild-type levels of cytotoxicity (Fig. 3). For example, complementation of the ΔvttRA strain with the pBAD18-vttRA construct occurred only with 0.5% arabinose, whereas a 10-fold-lower level of arabinose was sufficient to complement the ΔvttRB strain phenotype (Fig. 3). Our results are consistent with previously reported data showing that, in comparison to vttRA, lower levels of vttRB expression are sufficient to promote T3SS gene expression (32). Adding 0.01% to 0.2% arabinose both in the overnight culture of AM-19226 ΔvttRB(pBAD18-vttRB) and during coculture did not restore cytotoxicity, again suggesting either that vttRB expression was insufficient or, consistent with previously reported results, that vttRB overexpression produces a T3SS-null phenotype (32) (data not shown). Although it is unclear at this time whether posttranscriptional regulation is a contributing factor, it is possible that the amounts of protein required for wild-type regulation differ among target promoters. However, we are unable to definitively assess protein levels at this time since efforts aimed at antibody production and the production of tagged proteins have not provided reagents sufficient to conduct comparisons of protein levels from chromosomal versus episomally induced expression.
Previously reported results of studies using transcriptional reporter fusions suggested that VttRB acted downstream of VttRA, and the results of the present study indicate that a similar transcriptional hierarchy likely functions during mammalian cell coculture (32). Similar conclusions were drawn for the homologous T3SS regulatory proteins in Vibrio parahaemolyticus, VtrA and VtrB, based on data from complementation and electrophoretic mobility shift assays (36, 37). Interestingly, when the V. cholerae ΔvttRA strain was complemented by using vttRB, we observed cytotoxicity using a lower arabinose concentration than that for complementation with pBAD18-vttRA (Fig. 3). Our data indicate that dysregulation of vttRA also interferes with T3SS gene expression via vttRB, since the vopX deletion strain decreased both vttRB and structural gene expression levels and was not cytotoxic (Fig. 5). Results of transcriptional reporter fusion assays further support the conclusion that regulatory sequences governing vttRA expression extend beyond the 238-bp vopX-vttRA intergenic regions (Fig. 6A) and overlap the vopX open reading frame (Y. Patel, S. Kim, and M. Dziejman, unpublished data).
If we conclude that vttRB expression requires tight regulation to produce a WT T3SS phenotype, one interpretation of our collective data is that a single factor regulates vttRB expression to fine-tune levels or, alternatively, that ToxR, VttRA, and VttRB itself are all required to appropriately modulate vttRB expression levels (Fig. 6B). The two interpretations are not mutually exclusive, and additional data indicate that negative autoregulation may influence both vttRA and vttRB expression levels and that ToxR negatively regulates vttRA expression while positively influencing vttRB expression (31) (Fig. 6B). Our collective evidence therefore points to protein levels as an important facet of how VttRA and VttRB regulate T3SS gene expression, although as discussed above, definitive experiments await the development of sufficient reagents to detect protein levels.
We were surprised to find an absolute requirement for ToxR in the cytotoxicity assay, since T3SS gene expression in the ΔtoxR strain was moderately affected compared to that in the absence of VttRA or VttRB (31). In addition, a toxR deletion strain is moderately attenuated for colonization in the infant mouse model (∼10-fold) compared to strains deleted for vttRA or vttRB, which show more dramatic colonization defects (31). Our results suggest that the cytotoxicity assay is a very sensitive assay for T3SS function and that results can uncover even small perturbations in gene expression that affect activity. Regarding a role for ToxR, our current data suggest several possibilities: T3SS gene promoters may respond directly via ToxR interactions, indirectly through modulation of vttRB or vttRA expression, or indirectly by altering the expression of a currently unknown factor that contributes to T3SS regulation. Combined with previously reported results and our finding that vttRB expression levels are critical for T3SS regulation, we propose that ToxR is acting through vttRB to influence T3SS gene expression and activity (Fig. 6B).
We found that toxR expression at the highest arabinose concentration (Fig. 4) did not complement the toxR deletion, consistent with previously reported results showing that increased toxR expression in the wild-type AM-19226 strain leads to decreased trh-lacZ transcriptional reporter fusion expression (32). One interpretation is that overexpression simply results in protein aggregation or mislocalization. Alternatively, ToxR may act as a negative regulator of T3SS gene expression when expression levels exceed a certain threshold. In epidemic strains, plasmid-based ToxR overexpression can restore virulence gene expression, suggesting that the protein retains activity when produced at elevated transcriptional levels (38, 39). Again, however, we cannot make definitive conclusions about protein levels at this time.
In our current assay, Caco2-BBE cell cytotoxicity requires bile in the medium during V. cholerae coculture. Although bile could be acting on the V. cholerae cells to increase the expression of T3SS genes, expression of the vcsRTCNS2 T3SS structural gene operon during coculture with 0.2% bile is similar to that in the absence of bile (32). Several other possible explanations remain to be explored. We interpret the results of the gentamicin killing assay as consistent with the MOI data, which further suggest that Caco2-BBE cell death is due to bacterial cell-host cell interactions rather than a “domino effect” triggered early during coculture by the death of a subset of neighboring Caco2-BBE cells whose cytoplasmic contents are released into the coculture medium. This result is consistent with an increased bacterial burden but also with data indicating that adherence to Caco2-BBE cells requires ∼1.5 h of coculture (K. A. Miller, S. Gregoire, and M. Dziejman, unpublished data).
In summary, our collective results support the hypothesis that precise levels of vttRA and vttRB expression are an important component for wild-type regulation of T3SS gene expression. Furthermore, the ancestral toxR gene product contributes to the regulation of the horizontally acquired T3SS sequences, likely by regulating the expression of one or both of the T3SS genomic island-encoded transcriptional regulators. ToxR has a longstanding role as a critical component of virulence gene regulation in epidemic strains, where it controls hierarchical gene expression that governs the expression of the toxin-coregulated pilus and cholera toxin, which, like the T3SS, are laterally acquired virulence factors (1). It is interesting, then, that proteins encoded on the ancestral chromosome and proteins encoded on laterally acquired islands coordinately regulate virulence gene expression in strains carrying different virulence factors. The conserved topology and sequence similarity of VttRA, VttRB, and ToxR also suggest that the unique features of V. cholerae regulation may provide an advantage for this marine organism in its ability to respond to different environments encountered during its transient residence in the human host.
ACKNOWLEDGMENTS
We thank Jennifer Colquhoun and Ashfaqul Alam for strain construction, John Frelinger for experimental suggestions, Marty Pavelka for critically reading the manuscript, and the Dziejman laboratory for helpful discussions.
REFERENCES
- 1.Matson JS, Withey JH, DiRita VJ. 2007. Regulatory networks controlling Vibrio cholerae virulence gene expression. Infect Immun 75:5542–5549. doi: 10.1128/IAI.01094-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Childers BM, Klose KE. 2007. Regulation of virulence in Vibrio cholerae: the ToxR regulon. Future Microbiol 2:335–344. doi: 10.2217/17460913.2.3.335. [DOI] [PubMed] [Google Scholar]
- 3.Higgins DE, DiRita VJ. 1996. Genetic analysis of the interaction between Vibrio cholerae transcription activator ToxR and toxT promoter DNA. J Bacteriol 178:1080–1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Higgins DE, Nazareno E, DiRita VJ. 1992. The virulence gene activator ToxT from Vibrio cholerae is a member of the AraC family of transcriptional activators. J Bacteriol 174:6974–6980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Krukonis ES, Yu RR, DiRita VJ. 2000. The Vibrio cholerae ToxR/TcpP/ToxT virulence cascade: distinct roles for two membrane-localized transcriptional activators on a single promoter. Mol Microbiol 38:67–84. doi: 10.1046/j.1365-2958.2000.02111.x. [DOI] [PubMed] [Google Scholar]
- 6.Kovacikova G, Skorupski K. 2000. Differential activation of the tcpPH promoter by AphB determines biotype specificity of virulence gene expression in Vibrio cholerae. J Bacteriol 182:3228–3238. doi: 10.1128/JB.182.11.3228-3238.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kovacikova G, Lin W, Skorupski K. 2010. The LysR-type virulence activator AphB regulates the expression of genes in Vibrio cholerae in response to low pH and anaerobiosis. J Bacteriol 192:4181–4191. doi: 10.1128/JB.00193-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Xu X, Stern AM, Liu Z, Kan B, Zhu J. 2010. Virulence regulator AphB enhances toxR transcription in Vibrio cholerae. BMC Microbiol 10:3. doi: 10.1186/1471-2180-10-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Sack DA, Sack RB, Nair GB, Siddique AK. 2004. Cholera. Lancet 363:223–233. doi: 10.1016/S0140-6736(03)15328-7. [DOI] [PubMed] [Google Scholar]
- 10.Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. 2012. Cholera. Lancet 379:2466–2476. doi: 10.1016/S0140-6736(12)60436-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bagchi K, Echeverria P, Arthur JD, Sethabutr O, Serichantalergs O, Hoge CW. 1993. Epidemic of diarrhea caused by Vibrio cholerae non-O1 that produced heat-stable toxin among Khmers in a camp in Thailand. J Clin Microbiol 31:1315–1317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Dalsgaard A, Albert MJ, Taylor DN, Shimada T, Meza R, Serichantalergs O, Echeverria P. 1995. Characterization of Vibrio cholerae non-O1 serogroups obtained from an outbreak of diarrhea in Lima, Peru. J Clin Microbiol 33:2715–2722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Dalsgaard A, Forslund A, Bodhidatta L, Serichantalergs O, Pitarangsi C, Pang L, Shimada T, Echeverria P. 1999. A high proportion of Vibrio cholerae strains isolated from children with diarrhoea in Bangkok, Thailand are multiple antibiotic resistant and belong to heterogenous non-O1, non-O139 O-serotypes. Epidemiol Infect 122:217–226. doi: 10.1017/S0950268899002137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Dutta D, Chowdhury G, Pazhani GP, Guin S, Dutta S, Ghosh S, Rajendran K, Nandy RK, Mukhopadhyay AK, Bhattacharya MK, Mitra U, Takeda Y, Nair GB, Ramamurthy T. 2013. Vibrio cholerae non-O1, non-O139 serogroups and cholera-like diarrhea, Kolkata, India. Emerg Infect Dis 19:464–467. doi: 10.3201/eid1903.121156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Luo Y, Ye J, Jin D, Ding G, Zhang Z, Mei L, Octavia S, Lan R. 2013. Molecular analysis of non-O1/non-O139 Vibrio cholerae isolated from hospitalised patients in China. BMC Microbiol 13:52. doi: 10.1186/1471-2180-13-52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Morris JG Jr, Wilson R, Davis BR, Wachsmuth IK, Riddle CF, Wathen HG, Pollard RA, Blake PA. 1981. Non-O group 1 Vibrio cholerae gastroenteritis in the United States: clinical, epidemiologic, and laboratory characteristics of sporadic cases. Ann Intern Med 94:656–658. doi: 10.7326/0003-4819-94-5-656. [DOI] [PubMed] [Google Scholar]
- 17.Lee YL, Hung PP, Tsai CA, Lin YH, Liu CE, Shi ZY. 2007. Clinical characteristics of non-O1/non-O139 Vibrio cholerae isolates and polymerase chain reaction analysis of their virulence factors. J Microbiol Immunol Infect 40:474–480. [PubMed] [Google Scholar]
- 18.Sharma C, Thungapathra M, Ghosh A, Mukhopadhyay AK, Basu A, Mitra R, Basu I, Bhattacharya SK, Shimada T, Ramamurthy T, Takeda T, Yamasaki S, Takeda Y, Nair GB. 1998. Molecular analysis of non-O1, non-O139 Vibrio cholerae associated with an unusual upsurge in the incidence of cholera-like disease in Calcutta, India. J Clin Microbiol 36:756–763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Dziejman M, Balon E, Boyd D, Fraser CM, Heidelberg JF, Mekalanos JJ. 2002. Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease. Proc Natl Acad Sci U S A 99:1556–1561. doi: 10.1073/pnas.042667999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Chen Y, Johnson JA, Pusch GD, Morris JG Jr, Stine OC. 2007. The genome of non-O1 Vibrio cholerae NRT36S demonstrates the presence of pathogenic mechanisms that are distinct from those of O1 Vibrio cholerae. Infect Immun 75:2645–2647. doi: 10.1128/IAI.01317-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Chatterjee S, Ghosh K, Raychoudhuri A, Chowdhury G, Bhattacharya MK, Mukhopadhyay AK, Ramamurthy T, Bhattacharya SK, Klose KE, Nandy RK. 2009. Incidence, virulence factors, and clonality among clinical strains of non-O1, non-O139 Vibrio cholerae isolates from hospitalized diarrheal patients in Kolkata, India. J Clin Microbiol 47:1087–1095. doi: 10.1128/JCM.02026-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Dziejman M, Serruto D, Tam VC, Sturtevant D, Diraphat P, Faruque SM, Rahman MH, Heidelberg JF, Decker J, Li L, Montgomery KT, Grills G, Kucherlapati R, Mekalanos JJ. 2005. Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Proc Natl Acad Sci U S A 102:3465–3470. doi: 10.1073/pnas.0409918102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Faruque SM, Chowdhury N, Kamruzzaman M, Dziejman M, Rahman MH, Sack DA, Nair GB, Mekalanos JJ. 2004. Genetic diversity and virulence potential of environmental Vibrio cholerae population in a cholera-endemic area. Proc Natl Acad Sci U S A 101:2123–2128. doi: 10.1073/pnas.0308485100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Shin OS, Tam VC, Suzuki M, Ritchie JM, Bronson RT, Waldor MK, Mekalanos JJ. 2011. Type III secretion is essential for the rapidly fatal diarrheal disease caused by non-O1, non-O139 Vibrio cholerae. mBio 2:e00106-11. doi: 10.1128/mBio.00106-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Tam VC, Serruto D, Dziejman M, Brieher W, Mekalanos JJ. 2007. A type III secretion system in Vibrio cholerae translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization. Cell Host Microbe 1:95–107. doi: 10.1016/j.chom.2007.03.005. [DOI] [PubMed] [Google Scholar]
- 26.Alam A, Miller KA, Chaand M, Butler JS, Dziejman M. 2011. Identification of Vibrio cholerae type III secretion system effector proteins. Infect Immun 79:1728–1740. doi: 10.1128/IAI.01194-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Hiyoshi H, Kodama T, Saito K, Gotoh K, Matsuda S, Akeda Y, Honda T, Iida T. 2011. VopV, an F-actin-binding type III secretion effector, is required for Vibrio parahaemolyticus-induced enterotoxicity. Cell Host Microbe 10:401–409. doi: 10.1016/j.chom.2011.08.014. [DOI] [PubMed] [Google Scholar]
- 28.Suzuki M, Danilchanka O, Mekalanos JJ. 2014. Vibrio cholerae T3SS effector VopE modulates mitochondrial dynamics and innate immune signaling by targeting Miro GTPases. Cell Host Microbe 16:581–591. doi: 10.1016/j.chom.2014.09.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Tam VC, Suzuki M, Coughlin M, Saslowsky D, Biswas K, Lencer WI, Faruque SM, Mekalanos JJ. 2010. Functional analysis of VopF activity required for colonization in Vibrio cholerae. mBio 1:e00289-10. doi: 10.1128/mBio.00289-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Bankapalli LK, Mishra RC, Singh B, Raychaudhuri S. 2015. Identification of critical amino acids conferring lethality in VopK, a type III effector protein of Vibrio cholerae: lessons from yeast model system. PLoS One 10:e0141038. doi: 10.1371/journal.pone.0141038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Alam A, Tam V, Hamilton E, Dziejman M. 2010. vttRA and vttRB encode ToxR family proteins that mediate bile-induced expression of type three secretion system genes in a non-O1/non-O139 Vibrio cholerae strain. Infect Immun 78:2554–2570. doi: 10.1128/IAI.01073-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Miller KA, Hamilton E, Dziejman M. 2012. The Vibrio cholerae trh gene is coordinately regulated in vitro with type III secretion system genes by VttRA/VttRB but does not contribute to Caco2-BBE cell cytotoxicity. Infect Immun 80:4444–4455. doi: 10.1128/IAI.00832-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual, 2nd ed Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. [Google Scholar]
- 34.Chaand M, Dziejman M. 2013. Vibrio cholerae VttRA and VttRB regulatory influences extend beyond the type 3 secretion system genomic island. J Bacteriol 195:2424–2436. doi: 10.1128/JB.02151-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Guzman LM, Belin D, Carson MJ, Beckwith J. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol 177:4121–4130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kodama T, Gotoh K, Hiyoshi H, Morita M, Izutsu K, Akeda Y, Park KS, Cantarelli VV, Dryselius R, Iida T, Honda T. 2010. Two regulators of Vibrio parahaemolyticus play important roles in enterotoxicity by controlling the expression of genes in the Vp-PAI region. PLoS One 5:e8678. doi: 10.1371/journal.pone.0008678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Kodama T, Hiyoshi H, Okada R, Matsuda S, Gotoh K, Iida T. 2015. Regulation of Vibrio parahaemolyticus T3SS2 gene expression and function of T3SS2 effectors that modulate actin cytoskeleton. Cell Microbiol 17:183–190. doi: 10.1111/cmi.12408. [DOI] [PubMed] [Google Scholar]
- 38.Parsot C, Mekalanos JJ. 1990. Expression of ToxR, the transcriptional activator of the virulence factors in Vibrio cholerae, is modulated by the heat shock response. Proc Natl Acad Sci U S A 87:9898–9902. doi: 10.1073/pnas.87.24.9898. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Miller VL, Mekalanos JJ. 1984. Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR. Proc Natl Acad Sci U S A 81:3471–3475. doi: 10.1073/pnas.81.11.3471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Donnenberg MS, Kaper JB. 1991. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun 59:4310–4317. [DOI] [PMC free article] [PubMed] [Google Scholar]

